case_images: PMC10775172_01
case_images: Diffuse miliary nodules in both lungs were observed on chest CT.
case_images: j_biol-2022-0751-fig001.jpg
case_images: PMC10775172_01_j_biol-2022-0751-fig001.jpg
case_images: j_biol-2022-0751_fig_001
case_images: Diffuse miliary nodules in both lungs were observed on chest CT after 14 days of fever (Figures 1 and 2a).
case_images: (a) Diffuse miliary nodules were observed in both lungs 14 days after the onset of fever; (b) Patchy shadows in the lower and middle fields of both lungs 31 days after the onset of fever (3 days after empirical treatment; 5 days after admission). (c) After 46 days of treatment, no nodules or shadows were observed in either lung.
case_images: j_biol-2022-0751-fig002.jpg
case_images: PMC10775172_01_j_biol-2022-0751-fig002.jpg
case_images: j_biol-2022-0751_fig_002
case_images: Diffuse miliary nodules in both lungs were observed on chest CT after 14 days of fever (Figures 1 and 2a). Three days after empirical treatment (31 days after the onset of fever), the patient underwent a repeat chest CT, at which point, patchy shadows were observed in the lower and middle fields of both lungs (Figure 2b). After 46 days of treatment, the miliary nodules and patchy shadows disappeared in chest CT (Figure 2c).
case_images: (a) Two days after admission, chest X-ray showed multiple plaques in both lungs. (b) After 5 months of treatment, no high-density shadows were observed on chest X-ray.
case_images: j_biol-2022-0751-fig003.jpg
case_images: PMC10775172_01_j_biol-2022-0751-fig003.jpg
case_images: j_biol-2022-0751_fig_003
case_images: Two days after admission, a chest X-ray was completed, which showed multiple plaques in both lungs (Figure 3a). After 5 months of treatment, chest X-ray showed no discernible high-density shadows (Figure 3b).
case_images: Diagnosis and treatment of a case of acute lupus pneumonia. The first day of fever was recorded as D0. WBC: white blood cells, Hb: hemoglobin, PLT: platelet, C3: complement C3, C4: complement C4, T-SPOT: T-lymphocyte culture + interferon assay (A + B), PPD: tuberculin test, ANA: antinuclear antibodies, LA: lupus anticoagulant, anti-ACL: anti-cardiolipin antibodies, ANCA: neutrophil cytoplasmic antibodies, 24-h-Upro: 24-h urinary protein quantity, SLE: systemic lupus erythematosus, ALP: acute lupus pneumonitis, LN: lupus nephritis, IVIG: intravenous immunoglobulin, MP: methylprednisolone, HCQ: hydroxychloroquine, MMF: mycophenolate mofetil, i.v.: intravenous injection, po: orally, qd: once a day, bid: twice a day.
case_images: j_biol-2022-0751-fig004.jpg
case_images: PMC10775172_01_j_biol-2022-0751-fig004.jpg
case_images: j_biol-2022-0751_fig_004
case_images: Out of hospital, the patient was given prednisone, hydroxychloroquine, and mycophenolate mofetil (Figure 4).